August 19, 2019

Two Disruptive Healthcare Stocks

The Fool looks at two disruptive healthcare stocks.  One is Invitae, which looks to bring genetic testing to the masses.  The stock is growing by leaps and bounds and should continue to grow revenue as they gain the business of not just individuals, but insurance companies as well.  On analyst thinks that shares can hit $100, but that call seems a little ambitious at this stage in the game. 

The second stock is Inspire Medical systems, which has a new way of treating sleep apnea.  Many insurance providers (including United Health) are just now approving the device and the company has also begun selling their product in Europe.   

August 16, 2019

On Chart Industries

Chart Industries makes equipment for cryogenic gas.  A Fool article builds a good case for the stock and breaks down how they make their money. 

The most compelling buy argument from the article is as follows:

"But it's only a drop in the bucket compared to the massive wave of profits Chart should start riding in 2020, when tens of billions of dollars in LNG export facilities are expected to be constructed. According to the company's 2020 outlook, updated in June, management expects to earn between $8.00 and $8.75 per share if a handful of big deals on the verge of getting the green light do move forward next year.
Here's the good news: Even if those deals don't happen next year, Chart expects it will still earn between $5.05 and $5.35 per share next year. That's a substantial amount of earnings growth, even on the low end."

August 9, 2019

14 Small Cap Stocks to Buy Now

The Fool is out with an article titled "14 Small Cap Stocks to Buy Now."  Among those listed are Fastly, Redfin, and Upwork.